Timothy Hughes, MD, Giuseppe Saglio, MD, and Delphine Rea, MD, PhD

In this episode, “Individualizing Treatment in CML”, Timothy Hughes, MD, Giuseppe Saglio, MD, and Delphine Rea, MD, PhD consider emerging strategies in CML (chronic myeloid leukemia), including frontline TKI selection, resistance to TKIs, and treatment-free remission.

Long-term, deep molecular response is generally achievable for most patients when treatment is based on commonly accepted guidelines. However, some patients may benefit from a more individualized approach to TKI selection and sequence.

Share this story, choose your platform!